FDA Removes Some Warnings on Menopause Hormone Therapies

The US Food and Drug Administration (FDA) announced changes to warning labels for estrogen hormone therapies used to alleviate menopausal symptoms so that they more accurately represent their risks and benefits.

Authors

Publication Details

Journal
JAMA
Published
2025-12-05
DOI
https://doi.org/10.1001/jama.2025.20011
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA Removes Some Warnings on Menopause Hormone Therapies

Shravya Pant
JAMA
Menopause: Health Impacts and Treatments
article

FDA Removes Some Warnings on Menopause Hormone Therapies

Shravya Pant
article en

Abstract

The US Food and Drug Administration (FDA) announced changes to warning labels for estrogen hormone therapies used to alleviate menopausal symptoms so that they more accurately represent their risks and benefits.

JAMAVol. 335(1)
Openalex Percentile: Top 49%
Menopause: Health Impacts and Treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FDA Removes Some Warnings on Menopause Hormone Therapies — Shravya Pant · JAMA (2025) | TGRS Research Map | TGRS